Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priscilla Yam

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2003
HIV vector production mediated by Rev protein transductionClaudia M Kowolik, Priscilla Yam, Ying Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 2, 2006
Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cellsPriscilla Yam, Michael Jensen, Ramesh Akkina, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes-CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu Mouse-Derived T CellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectorsDavid Strayer, Francisco Branco, Mark A Zern, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2003
HIV vector production mediated by Rev protein transductionClaudia M Kowolik, Priscilla Yam, Ying Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 2, 2006
Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cellsPriscilla Yam, Michael Jensen, Ramesh Akkina, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2007
Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes-CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu Mouse-Derived T CellsJoseph Anderson, Ming-Jie Li, Brent Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectorsDavid Strayer, Francisco Branco, Mark A Zern, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Pageof 1